Conference Description:

This conference will be focused on analyzing and discussing the best practices and strategies for those preparing for audits and inspections.

- Quality and Compliance - Medical Information - Risk Management - Compliance - Pharmacovigilance Auditors - Management Staff Responsible for Running Inspections - Employees (directly and indirectly) Involved in Inspections - Drug/Product Safety - Drug Development - Information and Clinical Data Management - Clinical Pharmacology - Clinical Safety - Research & Development - Quality Assurance - Patient Safety - Signal Detection - Safety Surveillance - Outcome Research - Data Analysis - Epidemiology - Medical Affairs - Regulatory Affairs and Compliance - Information technology To this: ExL's Pharmacovigilance Audit and Inspection Conference will explore the recently revised PV guidelines as well as forward-thinking strategies that you will encounter. This conference will be focused on analyzing and discussing the best practices and strategies for those preparing for audits and inspections. The Pharmacovigilance Audit and Inspections conference will bring concrete answers and insights, through industry experiences, to deal with the freshly released GVP guidelines and the newest technologies that can be used to improve your organizational performance and reporting. The mission of this event is to further educate industry professionals on how to best utilize emerging technologies and innovative methods in Pharmacovigilance.

URLs:
Brochure: https://go.evvnt.com/186029-1?pid=154
Booking: https://go.evvnt.com/186029-2?pid=154

Price
Early Bird Pricing - Register by February 9, 2018: USD 1895
Standard Pricing: USD 2095
Onsite Pricing: USD 2195

Speakers: Deepa Arora Vice President Pharmacovigilance and Global Head, Drug Safety and Risk Management, LUPIN LIMITED, Deanna Montes de Oca Associate Director, PV Operations Clinical Safety and Pharmacovigilance, OTSUKA, Suzanne Elliott Director (Head), U.S. Medical Compliance, BOEHRINGER INGELHEIM, Sue Elliott Director, Pharmacovigilance Quality Assurance Leader, JAZZ PHARMACEUTICALS, Paula Engle Head of Global PV Compliance, Training and PV Network, GE HEALTHCARE, Marissa Fernandez Pharmacovigilance Manager, BAXTER HEALTHCARE CORPORATION, Patrick Hoegen Associate Director, PV Quality and Compliance, ALKERMES, Kevin Malobisky Senior Vice President Regulatory, Quality, and Pharmacovigilance, KARYOPHARM, Rena Pandit Director, Inspection Readiness Global Patient Safety and Epidemiology (GPSE), ALLERGAN, Fawad Piracha Risk Management, Pharmacovigilance/Risk Management, REGENERON PHARMACEUTICALS, INC, Sameer Thapar Assistant Professor and Advisor, Drug Safety and Pharmacovigilance Rutgers, THE STATE UNIVERSITY OF NEW JERSEY, Boris Videlov Head PV Licensing, PFIZER INCORPORATED, Susan Welsh Chief Safety Officer, CSL BEHRING, Richard Wolf Senior Director Regions and Pv Operations, Global Clinical Safety and Pharmacovigilance, CSL BEHRING

Time: 8:00 am to 3:30 pm